BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 23652187)

  • 1. [Bone cancer pain: from preclinical pharmacology to clinical trials].
    Montiel-Ruiz RM; Acosta-González RI; Jiménez Andrade JM
    Gac Med Mex; 2013; 149(2):204-11. PubMed ID: 23652187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
    Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
    Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone cancer pain.
    Jimenez-Andrade JM; Mantyh WG; Bloom AP; Ferng AS; Geffre CP; Mantyh PW
    Ann N Y Acad Sci; 2010 Jun; 1198():173-81. PubMed ID: 20536932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor.
    Iranikhah M; Wilborn TW; Wensel TM; Ferrell JB
    Pharmacotherapy; 2012 Mar; 32(3):274-84. PubMed ID: 22392458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin diminishes advanced bone cancer pain.
    Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
    Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Painful osseous metastases.
    Smith HS
    Pain Physician; 2011; 14(4):E373-403. PubMed ID: 21785487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of bone cancer pain.
    Sabino MA; Mantyh PW
    J Support Oncol; 2005; 3(1):15-24. PubMed ID: 15724942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-RANKL antibody for the management of bone metastasis].
    Yoneda T
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1439-45. PubMed ID: 21918338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging therapies in metastatic bone pain.
    Coluzzi F; Mandatori I; Mattia C
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):441-58. PubMed ID: 21545247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing metastatic bone pain: the role of bisphosphonates.
    Gralow J; Tripathy D
    J Pain Symptom Manage; 2007 Apr; 33(4):462-72. PubMed ID: 17397707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New targets, new drugs for metastatic bone pain: a new philosophy.
    Pantano F; Zoccoli A; Iuliani M; Lanzetta G; Vincenzi B; Tonini G; Santini D
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):403-5. PubMed ID: 21623686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone cancer pain: from model to mechanism to therapy.
    Luger NM; Mach DB; Sevcik MA; Mantyh PW
    J Pain Symptom Manage; 2005 May; 29(5 Suppl):S32-46. PubMed ID: 15907645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.
    Paes FM; Serafini AN
    Semin Nucl Med; 2010 Mar; 40(2):89-104. PubMed ID: 20113678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms that generate and maintain bone cancer pain.
    Mantyh PW; Hunt SP
    Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of bone metastases in breast cancer patients.
    Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
    Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A mechanism based understanding of cancer pain and development of novel strategies of cancer pain treatment].
    Kawamata T; Namiki A
    Masui; 2008 Jan; 57(1):39-50. PubMed ID: 18214004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of metastatic bone disease.
    Major P
    Eur J Oncol Nurs; 2007; 11 Suppl 2():S32-7. PubMed ID: 17804294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin and the tumorigenic component of bone cancer pain.
    Peters CM; Lindsay TH; Pomonis JD; Luger NM; Ghilardi JR; Sevcik MA; Mantyh PW
    Neuroscience; 2004; 126(4):1043-52. PubMed ID: 15207337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.